Summit Therapeutics (SMMT) Receivables Refunds (2018 - 2024)
Summit Therapeutics (SMMT) has disclosed Receivables Refunds for 6 consecutive years, with $557000.0 as the latest value for Q4 2024.
- For the quarter ending Q4 2024, Receivables Refunds fell 34.32% year-over-year to $557000.0, compared with a TTM value of $557000.0 through Dec 2024, down 34.32%, and an annual FY2024 reading of $557000.0, down 34.32% over the prior year.
- Receivables Refunds was $557000.0 for Q4 2024 at Summit Therapeutics, down from $660000.0 in the prior quarter.
- Across five years, Receivables Refunds topped out at $15.7 million in Q4 2021 and bottomed at $557000.0 in Q4 2024.
- Average Receivables Refunds over 5 years is $7.2 million, with a median of $6.8 million recorded in 2020.
- The sharpest move saw Receivables Refunds soared 93.86% in 2020, then plummeted 93.73% in 2023.
- Year by year, Receivables Refunds stood at $9.9 million in 2020, then skyrocketed by 59.24% to $15.7 million in 2021, then plummeted by 63.26% to $5.8 million in 2022, then plummeted by 85.29% to $848000.0 in 2023, then plummeted by 34.32% to $557000.0 in 2024.
- Business Quant data shows Receivables Refunds for SMMT at $557000.0 in Q4 2024, $660000.0 in Q3 2024, and $953000.0 in Q2 2024.